Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothrombinex VF versus fresh frozen plasma for non-surgical bleeding after cardiopulmonary bypass
ACTRN12613001279718Phase 2Recruiting
- Sponsor
- Dr Warren Pavey
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Bleeding comparing Prothrombinex VF with Fresh frozen plasma (2 arms). Primary endpoints: Composite transfusion endpoint and Total cost of treatment. Started Feb 2016; status: recruiting.
02
Drugs
prothrombin complexfresh-frozen plasma
03
Conditions
Bleeding
Beyond the preview
Go deeper on ACTRN12613001279718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001279718.